​

Haleon (HLN) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChartTranscripts

Haleon Revenue Highlights

Latest Revenue (Y)

$11.30B

Latest Revenue (Q)

$2.92B

Main Segment (Y)

Respiratory Health

Main Geography (Y)

Rest of World

Haleon Revenue by Period

Haleon Revenue by Year

DateRevenueChange
2023-12-31$11.30B4.09%
2022-12-31$10.86B13.76%
2021-12-31$9.54B-3.51%
2020-12-31$9.89B16.65%
2019-12-31$8.48B-

Haleon generated $11.30B in revenue during NA 2023, up 4.09% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Haleon Revenue by Quarter

DateRevenueChange
2024-03-31$2.92B5.53%
2023-12-31$2.77B-1.14%
2023-09-30$2.80B1.67%
2023-06-30$2.75B-7.84%
2023-03-31$2.99B-21.28%
2022-12-31$3.79B31.15%
2022-09-30$2.89B12.92%
2022-06-30$2.56B-2.51%
2022-03-31$2.63B79.32%
2021-12-31$1.47B-41.16%
2021-09-30$2.49B-

Haleon generated $2.92B in revenue during Q1 2024, up 5.53% compared to the previous quarter, and up 76.96% compared to the same period a year ago.

Haleon Revenue Breakdown

Haleon Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22
Respiratory Health$1.58B

Haleon's latest annual revenue breakdown by segment (product or service), as of Dec 22: Respiratory Health (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 23
Respiratory Health$839.00M

Haleon's latest quarterly revenue breakdown by segment (product or service), as of Jun 23: Respiratory Health (100.00%).

Haleon Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22
CHINA$907.00M
Rest of World$5.91B
UNITED STATES$3.69B

Haleon's latest annual revenue breakdown by geography, as of Dec 22: Rest of World (56.24%), UNITED STATES (35.13%), and CHINA (8.63%).

Haleon Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
TAKTakeda Pharmaceutical$4.26T$1.05T
RDYDr. Reddy's Laboratories$279.16B-
TEVATeva Pharmaceutical Industries$16.54B$4.33B
VTRSViatris$14.74B$3.74B
HLNHaleon$11.30B$2.92B
BHCBausch Health Companies$9.52B$2.51B
ZTSZoetis$9.26B$2.39B
ELANElanco Animal Health$4.44B$1.18B
NBIXNeurocrine Biosciences$2.36B$622.10M
LNTHLantheus$1.53B$378.73M
EBSEmergent BioSolutions$1.04B$254.70M
HCMHUTCHMED (China)$838.00M$152.84M
ESPREsperion Therapeutics$332.31M$51.63M
SIGASIGA$138.72M$10.01M

HLN Revenue FAQ

What is Haleon’s yearly revenue?

Haleon's yearly revenue for 2023 was $11.3B, representing an increase of 4.09% compared to 2022. The company's yearly revenue for 2022 was $10.86B, representing an increase of 13.76% compared to 2021. HLN's yearly revenue for 2021 was $9.54B, representing a decrease of -3.51% compared to 2020.

What is Haleon’s quarterly revenue?

Haleon's quarterly revenue for Q1 2024 was $2.92B, a 5.53% increase from the previous quarter (Q4 2023), and a -2.24% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $2.77B, a -1.14% decrease from the previous quarter (Q3 2023), and a -27.08% decrease year-over-year (Q4 2022). HLN's quarterly revenue for Q3 2023 was $2.8B, a 1.67% increase from the previous quarter (Q2 2023), and a -3.25% decrease year-over-year (Q3 2022).

What is Haleon’s revenue growth rate?

Haleon's revenue growth rate for the last 3 years (2021-2023) was 18.41%, and for the last 5 years (2019-2023) was 33.28%.

What are Haleon’s revenue streams?

Haleon's revenue streams in c 22 are Respiratory Health

What is Haleon’s main source of revenue?

For the fiscal year ending Dec 22, the largest source of revenue of Haleon was Respiratory Health. This segment made a revenue of $1.58B, representing 100.00% of the company's total revenue.